Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maurizio Sassi
Observed names:
M. Sassi,
SASSI M,
SASSI M.
Observed institutions:
Azienda Ospedaliera di Perugia,
Azienda Ospedaliera San Camillo-Forlanini,
Santa Maria Nuova Hospital,
Carlo Forlanini Hospital,
Instituto Nazionale Tumori Regina Elena,
University of Turin
show all 6
OpenAlex ID:
A5078439823
Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project
1999
·
L. Crinò
, G. V. Scagliotti
, et al.
·
Journal of Clinical Oncology
·
365
Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales
1991
·
F. Roila
, M. Lupattelli
, et al.
·
Annals of Oncology
·
138
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: Results of a multicentric Italian study
1994
·
F. Boccardo
, A. Rubagotti
, et al.
·
Annals of Oncology
·
134
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial
1992
·
F. Boccardo
, A. Rubagotti
, et al.
·
European Journal of Cancer
·
57
Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial
1990
·
Riccardo Rosso
, Franco Salvati
, et al.
·
Cancer
·
52
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis
1991
·
F. Roila
, C. Basurto
, et al.
·
European Journal of Cancer and Clinical Oncology
·
20
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)
2000
·
C. Boni
, G. Bisagni
, et al.
·
International Journal of Cancer
·
9
Italian Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group Trials
1998
·
F. Boccardo
, A. Rubagotti
, et al.
·
Recent results in cancer research/Recent Results in Cancer Research
·
7
Neoadjuvant Chemotherapy with Continuous Infusion of Cisplatin and Fluorouracil in Stage II-IV, M0 Squamous Cell Carcinoma of the Head and Neck
1996
·
Corrado Boni
, Gabriella Moretti
, et al.
·
Tumori Journal
·
6
Ifosfamide Bolus Followed by Five Days Continuous Infusion in Extensively Pretreated Patients with Advanced Breast Cancer: A Phase II Study
1998
·
Giancarlo Bisagni
, Corrado Boni
, et al.
·
Tumori Journal
·
3
Inappropriate Doses of Chemotherapy in Italian Breast Cancer Patients Enrolled in Clinical Trials
2007
·
Enzo Ballatori
, Fausto Roila
, et al.
·
Tumori Journal
·
2
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
1998
·
C. Boni
, L. Savoldi
, et al.
·
European Journal of Cancer
·
2
Italian Breast Cancer Adjiuvant Chemo-Hormone Therapy Cooperative Group Trials. GROCTA Trials.
1998
·
BOCCARDO F
, RUBAGOTTI A
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Chemotherapy versus Tamoxifen versus Chemotherapy plus Tamoxifen. Results of the GROCTA Trial
1995
·
Francesco Boccardo
, Alessandra Rubagotti
, et al.
·
Beiträge zur Onkologie/Contributions to oncology
Ovarian ablation (OO) versus zoladex (Z) ± tamoxifen (T) in preperimenopausal patients (pts) with advanced breast cancer: Results of a multicentric randomized trial
1993
·
F. Boccardo
, A. Rubagotti
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
18
Citation count:
795
H-index:
7
I10-index:
6
Year
Topic
Type